ArticleProstate international2015

Importance of cycles of chemotherapy and postdocetaxel novel therapies in metastatic castration-resistant prostate cancer.

Darren M C Poon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.